A detailed history of Brinker Capital Investments, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 49,587 shares of ZTS stock, worth $8.21 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
49,587
Previous 51,618 3.93%
Holding current value
$8.21 Million
Previous $7.65 Million 5.04%
% of portfolio
0.15%
Previous 0.16%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

SELL
$131.14 - $157.47 $266,345 - $319,821
-2,031 Reduced 3.93%
49,587 $7.27 Million
Q3 2022

Nov 01, 2022

SELL
$148.29 - $182.55 $162,377 - $199,892
-1,095 Reduced 2.08%
51,618 $7.65 Million
Q2 2022

Jul 18, 2022

SELL
$155.97 - $200.09 $191,219 - $245,310
-1,226 Reduced 2.27%
52,713 $9.06 Million
Q1 2022

May 16, 2022

SELL
$181.39 - $234.03 $144,567 - $186,521
-797 Reduced 1.46%
53,939 $10.2 Million
Q4 2021

Feb 08, 2022

BUY
$193.69 - $247.03 $1.5 Million - $1.91 Million
7,744 Added 16.48%
54,736 $13.4 Million
Q2 2021

Aug 03, 2021

BUY
$155.9 - $187.99 $218,415 - $263,373
1,401 Added 3.07%
46,992 $8.76 Million
Q1 2021

May 12, 2021

SELL
$144.0 - $169.39 $1.62 Million - $1.9 Million
-11,241 Reduced 19.78%
45,591 $7.18 Million
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $1.97 Million - $2.19 Million
12,540 Added 28.31%
56,832 $9.41 Million
Q3 2020

Dec 03, 2020

BUY
$137.1 - $165.37 $6.07 Million - $7.32 Million
44,292 New
44,292 $7.33 Million
Q4 2019

Feb 06, 2020

SELL
$116.25 - $133.25 $14,880 - $17,056
-128 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$112.57 - $128.43 $14,408 - $16,439
128 New
128 $16,000
Q3 2018

Nov 13, 2018

SELL
$83.5 - $93.23 $6,680 - $7,458
-80 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$79.9 - $89.2 $6,392 - $7,136
80 New
80 $7,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.